Comparison of the efficacy of trastuzumab emtansine between patients with metastatic human epidermal growth factor receptor 2-positive breast cancers previously treated with combination trastuzumab and pertuzumab and with trastuzumab only in Japanese population

被引：0
|
作者：
Shoko Noda-Narita
Akihiko Shimomura
Asuka Kawachi
Hitomi Sumiyoshi-Okuma
Kazuki Sudo
Tatsunori Shimoi
Emi Noguchi
Kan Yonemori
Chikako Shimizu
Yasuhiro Fujiwara
Kenji Tamura
机构：
[1] National Cancer Center Hospital,Department of Breast and Medical Oncology
[2] National Center for Global Health and Medicine,Department of Breast Medical Oncology
来源：
Breast Cancer | 2019年 / 26卷
关键词：
Trastuzumab emtansine; Metastatic breast cancer; Human epidermal growth factor 2; Trastuzumab; Pertuzumab;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：492 / 498
页数：6
相关论文
共 50 条
  • [21] Trastuzumab: A Milestone in Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer
    Dhanushkodi, Manikandan
    INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY, 2020, 41 (01) : 54 - 56
  • [22] Incidence and Management of Diarrhea With Adjuvant Pertuzumab and Trastuzumab in Patients With Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer
    Bines, Jose
    Procter, Marion
    Restuccia, Eleonora
    Viale, Giuseppe
    Zardavas, Dimitrios
    Suter, Thomas
    Arahmani, Amal
    Van Dooren, Veerle
    Baselga, Jose
    Clark, Emma
    Eng-Wong, Jennifer
    Gelber, Richard D.
    Piccart, Martine
    Mobus, Volker
    de Azambuja, Evandro
    CLINICAL BREAST CANCER, 2020, 20 (02) : 174 - +
  • [23] Safety and Efficacy of Trastuzumab Emtansine in Advanced Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: a Meta-analysis
    Shen, Kai
    Ma, Xuelei
    Zhu, Chenjing
    Wu, Xin
    Jia, Hongyuan
    SCIENTIFIC REPORTS, 2016, 6
  • [24] T-DM1 Activity in Metastatic Human Epidermal Growth Factor Receptor 2-Positive Breast Cancers That Received Prior Therapy With Trastuzumab and Pertuzumab
    Dzimitrowicz, Hannah
    Berger, Michael
    Vargo, Craig
    Hood, Annette
    Abdelghany, Osama
    Raghavendra, Akshara Singareeka
    Tripathy, Debu
    Valero, Vicente
    Hatzis, Christos
    Pusztai, Lajos
    Murthy, Rashmi
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (29) : 3511 - +
  • [25] The survival outcomes for the subsequent therapy after treatment with trastuzumab emtansine in human epidermal growth factor receptor 2-positive metastatic breast cancer patients
    Watanuki, R.
    Shimomura, A.
    Yazaki, S.
    Narita, S.
    Okuma, H.
    Nishikawa, T.
    Tanioka, M.
    Sudo, K.
    Shimoi, T.
    Noguchi, E.
    Kan, Y.
    Tamura, K.
    EUROPEAN JOURNAL OF CANCER, 2020, 138 : S62 - S62
  • [26] Lapatinib plus trastuzumab in pretreated human epidermal growth factor receptor 2-positive metastatic breast cancer
    Sotelo, Miguel J.
    Angel Garcia-Saenz, Jose
    Manso, Luis
    Moreno, Fernando
    Ciruelos, Eva
    Callata, Hector R.
    Mendiola, Cesar
    Cabezas, Santiago
    Ghanem, Ismael
    Diaz-Rubio, Eduardo
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2014, 10 (04) : 967 - 972
  • [27] Substituting adjuvant trastuzumab emtansine for Herceptin improves survival in patients with human epidermal growth factor receptor 2-positive breast cancer
    Printz, Carrie
    CANCER, 2019, 125 (08) : 1213 - 1213
  • [28] Efficacy and safety of Trastuzumab Emtansine in treating human epidermal growth factor receptor 2-positive metastatic breast cancer in Chinese population: a real-world multicenter study
    He, Miao
    Zhao, Wen
    Wang, Peng
    Li, Wenhuan
    Chen, Hanhan
    Yuan, Zonghuai
    Pan, Guangye
    Gao, Hong
    Sun, Lijun
    Chu, Jiahui
    Li, Li
    Hu, Yu
    FRONTIERS IN MEDICINE, 2024, 11
  • [29] Ado-trastuzumab emtansine for the treatment of human epidermal growth factor receptor 2 positive metastatic breast cancer
    Patel, Kiki
    Hageman, Kelly
    Cooper, Maryann
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2014, 71 (07) : 537 - 548
  • [30] Trastuzumab Emtansine With or Without Pertuzumab Versus Trastuzumab Plus Taxane for Human Epidermal Growth Factor Receptor 2-Positive, Advanced Breast Cancer: Primary Results From the Phase III MARIANNE Study
    Perez, Edith A.
    Barrios, Carlos
    Eiermann, Wolfgang
    Toi, Masakazu
    Im, Young-Hyuck
    Conte, Pierfranco
    Martin, Miguel
    Pienkowski, Tadeusz
    Pivot, Xavier
    Burris, Howard, III
    Petersen, Jennifer A.
    Stanzel, Sven
    Strasak, Alexander
    Patre, Monika
    Ellis, Paul
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (02) : 141 - +
12345